Yulan Huang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Macrophage PABPC4-SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 02, 2026
The TP53-LGALS4 axis modulates the tumor immune microenvironment and synergizes with anti PD-L1 therapy in colorectal cancer.
Journal: Journal of translational medicine
Published: September 18, 2025
Tumor-intrinsic FDFT1 determines coordinated macrophage anti-tumor immunity.
Journal: Developmental cell
Published: August 30, 2025
Glutamine-driven upregulation of NPDC1 promotes colorectal cancer progression through PI3K/AKT signaling.
Journal: Journal of translational medicine
Published: August 07, 2025
Malate targets pyruvate kinase M2 to promote colorectal cancer cell cycle arrest and tumor suppression.
Journal: Molecular biomedicine
Published: May 27, 2025
The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.
Journal: Acta pharmaceutica Sinica. B
Published: August 28, 2023
Physical- and Chemical-Dually ROS-Responsive Nano-in-Gel Platforms with Sequential Release of OX40 Agonist and PD-1 Inhibitor for Augmented Combination Immunotherapy.
Journal: Nano letters
Published: February 13, 2023
Carrier-Free Nanomedicine for Cancer Immunotherapy.
Journal: Journal of biomedical nanotechnology
Published: July 20, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026